ICH E6 (R3) Guideline on good clinical practice (GCP)
International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use
GOOD CLINICAL PRACTICE (GCP) E6(R3) Step 5
23 January 2025. Date for coming into effect 23 July 2025
ICH E6(R3) introduces innovative provisions designed to apply across various types and settings of clinical trials, ensuring continued relevance in the face of ongoing technological and methodological advancements. This guideline provides a new language to facilitate innovations in clinical trial design, technology, and operational approaches. It encourages a risk-based and proportionate approach to conducting clinical trials, promoting fit-for-purpose solutions. It fosters transparency through clinical trial registration and result reporting and offers additional guidance to enhance the informed consent process.
The overarching principles and Annex 1, adopted by ICH and CHMP, came into effect on 23 July 2025.
With the public consultation now concluded, the Annex 2 is expected to be finalised later in 2025.
I. INTRODUCTION
II. PRINCIPLES OF ICH GCP
III. ANNEX 1
1. INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)
2. INVESTIGATOR
3. SPONSOR
4. DATA GOVERNANCE – INVESTIGATOR AND SPONSOR
Appendix A. INVESTIGATOR’S BROCHURE
Appendix B. CLINICAL TRIAL PROTOCOL AND PROTOCOL AMENDMENT(S)
Appendix C. ESSENTIAL RECORDS FOR THE CONDUCT OF A CLINICAL TRIAL
GLOSSARY
© European Medicines Agency, 2025. Reproduction is authorised provided the source is acknowledged.
Official address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands
Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us
Send a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000
Clinical Research News
Kommende kliniske studier
-
Intuitive SurgicalHar ikke rekruttert ennå
-
Bristol-Myers SquibbHar ikke rekruttert ennå
-
University of Alabama at BirminghamHar ikke rekruttert ennåSpinal Cord DisordersForente stater
-
Medical University of ViennaHar ikke rekruttert ennåVaskulær tilgang | Vaskulær tilgangskomplikasjon | Dialysekateterinfeksjoner | Hemodialyse | Hemodialysekomplikasjon | Dysfunksjon i dialysetilgang | ESRD (sluttstadium nyresykdom) | DialysekateterØsterrike
-
NYU Langone HealthNational Cancer Institute (NCI)Har ikke rekruttert ennåProstatakreftForente stater
-
M.D. Anderson Cancer CenterHar ikke rekruttert ennåKutant angiosarkomForente stater
-
Helwan UniversityHar ikke rekruttert ennå
-
Prevention Strategies, LLCNational Institute on Drug Abuse (NIDA); NORC at the University of ChicagoHar ikke rekruttert ennåAlkoholrelaterte lidelser | Tobakksbruksforstyrrelse | Marihuana bruk | Stoffrelaterte lidelser
-
Second Affiliated Hospital of Nanchang UniversityBeijing Pearl Biotechnology Limited Liability CompanyRekruttering
-
Ming LiuHar ikke rekruttert ennåGastrisk adenokarsinom | Gastroøsofageal Junction AdenocarcinomaKina
-
The First Affiliated Hospital of Soochow UniversityHar ikke rekruttert ennåGastriske submukosale svulster
-
Peking University First HospitalPeking University Shenzhen HospitalHar ikke rekruttert ennåEldre pasienter | Kreftkirurgi | Målrettet temperaturstyring | Hypotermi, utilsiktet | Forsinket nevrokognitiv utvinningKina
Clinical Research Jobs
-
United Kingdom - London
-
United States - Reno
-
United States - North Carolina - Durham
-
Poland - Krakow
-
Japan - Tokyo
-
India - Bengaluru
-
United States - North Carolina - Morrisville
-
China